{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:40:40Z","timestamp":1759916440475,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.maturitas.2015.07.001","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T01:01:44Z","timestamp":1436403704000},"page":"197-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ovarian cancer in BRCA1\/2 mutation carriers: The impact of mutation position and family history on the cancer risk"],"prefix":"10.1016","volume":"82","author":[{"given":"Natalia","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian J.E.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorina M.van der","family":"Kolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.de","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2015.07.001_bib0005","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0010","unstructured":"International Agency for Research on Cancer \u2013EUREG \u2013Incidence rates from 2000 to 2007. http:\/\/eco.iarc.fr\/EUREG\/Table.aspx#34 accessed on November 23, 2014."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0015","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","article-title":"Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age","volume":"124","author":"Kolk","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0035","first-page":"329","article-title":"Variation in BRCA1 cancer risks by mutation position","volume":"11","author":"Thompson","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:FAME.0000026816.32400.45","article-title":"Cancer variation associated with the position of the mutation in the BRCA2 gene","volume":"3","author":"Lubinski","year":"2004","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00016340902807207","article-title":"Risk of ovarian cancer in women with first-degree relatives with cancer","volume":"88","author":"Soegaard","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1055-9965.EPI-05-0687","article-title":"Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations","volume":"15","author":"Lee","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.1998.tb10148.x","article-title":"A systematic review and meta analysis of family history and risk of ovarian cancer","volume":"105","author":"Stratton","year":"1998","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0060","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.11151","article-title":"Familial invasive and borderline ovarian tumors by proband status, age and histology","volume":"105","author":"Hemminki","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0065","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0511301103","article-title":"Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population","volume":"103","author":"Simchoni","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/jnci\/djq443","article-title":"Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations","volume":"102","author":"Metcalfe","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2011.10.008","article-title":"Model of care for women at increased risk of breast and ovarian cancer","volume":"71","author":"De Bock","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.09.009","article-title":"Managing hereditary ovarian cancer","volume":"64","author":"Mourits","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0085","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.ejca.2013.02.018","article-title":"Proven non-carriers in BRCA families have an earlier age of onset of breast cancer","volume":"49","author":"Vos","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0090","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1055-9965.EPI-13-1279","article-title":"Variation in mutation spectrum partly explains regional differences in the breast cancer risk of female BRCA mutation carriers in the Netherlands","volume":"23","author":"Vos","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation in risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0100","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Rish","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0105","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0959-8049(01)00244-1","article-title":"Large regional differences in the frequency of distinct BRCA1\/BRCA2 mutations in 517 Dutch breast and\/or ovarian cancer families","volume":"37","author":"Verhoog","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0110","first-page":"1041","article-title":"A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families","volume":"60","author":"Peelen","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","article-title":"Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers?","volume":"124","author":"van der Velde","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0120","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":"No efficacy of annual gynecological screening in BRCA1\/2 mutation carriers; an observational follow-up study","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.maturitas.2015.07.001_bib0125","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0130","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk reducing salpingo-oophorectomy in women with BRCA-1 or BRCA-2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA-1 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1\/2 mutation carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2015.07.001_bib0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2012.07.021","article-title":"Support of the \u2018fallopian tube hypothesis\u2019 in a prospective series of risk-reducing salpingo-oophorectomy specimens","volume":"49","author":"Reitsma","year":"2013","journal-title":"Eur. J. Cancer"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:02:58Z","timestamp":1759914178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512215300086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0378512215300086"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.07.001","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian cancer in BRCA1\/2 mutation carriers: The impact of mutation position and family history on the cancer risk","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}